Skip to content
Search

Latest Stories

Pharmacy2U snaps up LloydsDirect, uniting UK's top online pharmacies

Pharmacy2U has recently acquired LloydsDirect in a confidential deal, bringing together two of the UK's foremost online pharmacies. Over time, both entities will integrate their operations under the Pharmacy2U brand, the companies said in a joint statement.

The two businesses complement each other effectively, and their teams will now work closely together to uphold the patient-centric approach and service quality for which both are known individually, the statement added. However, there is currently limited clarity regarding the sale process and its impact on Lloyds staff.


According to NHS Business Services Authority data from PharmData, Pharmacy2U dispensed 1,528,436 items in June 2023, while LloydsDirect, previously owned by LloydsPharmacy, dispensed 1,142,891 items. This positions them as the top two online prescription pharmacies for items dispensed, with Well.co.uk in third place at 128,691 items.

"We are delighted to welcome the LloydsDirect team to the Pharmacy2U family," said Kevin Heath, CEO of Pharmacy2U. "Their remarkable accomplishments over the past eight years, particularly in enhancing patient experience and prioritising sustainability, have been impressive. By blending the strengths of both our enterprises, we can offer patients enhanced access and convenience."

Heath emphasised that both companies offer dedicated leadership, a profound commitment to pharmacy, and an extended range of digital health offerings, complemented by cutting-edge dispensing technology. “We are enthusiastic about uniting two enterprises united by patient-centric values and online proficiency to advance the benefits of pharmacy for the NHS and its patients," he added.

“First and foremost, we believe this will benefit our patients and our efforts in supporting the NHS," added Connie Cha, Managing Director of LloydsDirect. "The achievements of both businesses highlight the dedication of the Pharmacy2U and LloydsDirect teams in providing accessible and convenient pharmacy services to assist patients in managing their prescriptions and overall health."

"We anticipate collaborating as a unified pharmacy team, utilising state-of-the-art technology and automation in dispensing, while also expanding access to digital services in the days ahead," Cha further said.

Pharmacy2U has been investing in resources to advanced clinical care and automated dispensing technology, modernising access to NHS services and broadening its health e-commerce offerings, the statement said. Established in 1999, the company currently serves over 750,000 patients across England, and reported a pre-tax profit of £2.9 million from revenues of £165.1 million for the fiscal year ending in March 2022.

LloydsDirect, initially known as Echo, started in 2015. It was acquired by McKesson UK, then-owners of LloydsPharmacy, in 2019 and was rebranded to its current name in July 2021. In November 2021, the LloydsPharmacy group was bought for £477 million by private equity company the Aurelius Group. Under the new ownership, the company experienced substantial divestment of its assets.

Meanwhile, the NHS Business Services Authority (NHSBSA) recently confirmed a net decrease of 101 pharmacies in England for the year ending March 31, 2023, compared to the previous period. This comprises 371 closures and 270 new contracts. Additionally, data from the General Pharmaceutical Council projected a decrease of 43 registered pharmacies in England, Wales, and Scotland during the same period.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less